Patent Assignment
Reel/Frame 061042/0574
Assignment of Assignor's Interest
Recorded: 2022-09-09
Pages: 10
Assignors
WARNER, STEVEN L.
Executed: 2020-03-02
SIDDIQUI-JAIN, ADAM
Executed: 2020-02-24
FLYNN, PAUL
Executed: 2020-02-21
Assignee
TOLERO PHARMACEUTICALS, INC.
3900 N. TRAVERSE MOUNTAIN BLVD., LEHI, UTAH, 84043
Covered Property
(1)
Formulations Comprising Heterocyclic Protein Kinase Inhibitors
Application:
17/930,015 →
Publication:
US 2023/0233557
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Sep 9, 2022
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 061042/0688 →
Change of Name
Sep 9, 2022
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 061405/0345 →
Change of Name
Sep 9, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 061405/0353 →
Merger
Sep 18, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068618/0375 →